Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Copper histidinate - Cyprium Therapeutics/Sentynl Therapeutics

Next Previous
Drug Profile

Copper histidinate - Cyprium Therapeutics/Sentynl Therapeutics

Alternative Names: Copper histidine - Cyprium Therapeutics/Sentynl Therapeutics; CUTX 101; Zycubo

Latest Information Update: 14 Jan 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cyprium Therapeutics
  • Developer Cyprium Therapeutics; National Institute of Child Health and Human Development
  • Class Amines; Amino acids; Heavy metals; Imidazoles; Propionic acids; Small molecules
  • Mechanism of Action Heavy metal replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Menkes kinky hair syndrome
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Menkes kinky hair syndrome

Most Recent Events

  • 14 Jan 2026 Chemical structure information added.
  • 12 Jan 2026 The US FDA issues rare paediatric disease priority review voucher to Sentynl Therapeutics
  • 12 Jan 2026 Registered for Menkes kinky hair syndrome (In adolescents, In children, In infants, In neonates) in USA (SC) - First global approval

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top